Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2022; 47(3): 585-588


The effectiveness of pharmacological treatment for adenomyosis with GnRH and LNG-IUS post adenomyomectomy at Shaikh Zaid Woman Hospital Larkana Pakistan

Saeedunisa Sangi, Shabnum Naz Shaikh, Ahmed Bux Shaikh, Sumera Brohi, Shazia Shaikh, Shaista Hifaz Abro.




Abstract

Objective: To compare effectiveness of pharmacological treatment for adenomyosis with GnRH and LNG-IUS post adenomyomectomy.
Methodology: This randomized controlled trial was conducted at Chandka Medical College Larkana from May 2018 to May 2020. The enrollment criteria included all women between the ages of 18 and 45 years; symptomatic patients with Visual Analog Scale (VAS) scores >3 points; diagnosed with focal or diffuse adenomyosis; and post-operative histopathological confirmation of adenomyosis. We divided 150 patients in three groups having 50 patients in each group. In-group A GnRH was given, in-group B LNG-IUS was given and in Group C, no pharmacological treatment given postoperatively. All patients had regular three follow-up at two weekly intervals and VAS pain scores were recorded postoperatively and at each follow-up visit.
Results: VAS scores of all patients decreased from 7.0 (0.6) to 4 (0.3) at the 6 months, postoperatively. The postoperative VAS was significantly higher in-group C (no medical treatment) compared to group A and B, (p

Key words: Adenomyosis, GnRH, LNG-IUS and Post adenomyomectomy.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.